Targeted therapies in lung cancer

被引：35

作者：

Besse, B.

Ropert, S.

Soria, J. C.

机构：

[1] Inst Gustave Roussy, Dept Med, F-94800 Villejuif, France

[2] Hop Cochin, GHU Ouest, Dept Oncol, F-75674 Paris, France

来源：

ANNALS OF ONCOLOGY | 2007年 / 18卷

关键词：

GROWTH-FACTOR-RECEPTOR; PHASE-II TRIAL; PROTEIN-KINASE-C; TRANSFERASE INHIBITOR R115777; MATRIX-METALLOPROTEINASE; TYROSINE KINASE; ANTISENSE OLIGONUCLEOTIDE; ACTIVATING MUTATIONS; UNTREATED PATIENTS; IMPROVED SURVIVAL;

D O I：

10.1093/annonc/mdm308

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：135 / 142

页数：8

共 91 条

[21] Sorafenib in advanced clear-cell renal-cell carcinoma [J].

Escudier, Bernard ;

Eisen, Tim ;

Stadler, Walter M. ;

Szczylik, Cezary ;

Oudard, Stephane ;

Siebels, Michael ;

Negrier, Sylvie ;

Chevreau, Christine ;

Solska, Ewa ;

Desai, Apurva A. ;

Rolland, Frederic ;

Demkow, Tomasz ;

Hutson, Thomas E. ;

Gore, Martin ;

Freeman, Scott ;

Schwartz, Brian ;

Shan, Minghua ;

Simantov, Ronit ;

Bukowski, Ronald M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :125-134

[22] Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer [J].

Fanucchi, Michael P. ;

Fossella, Frank V. ;

Belt, Robert ;

Natale, Ronald ;

Fidias, Panos ;

Carbone, David P. ;

Govindan, Ramaswamy ;

Raez, Luis E. ;

Robert, Francisco ;

Ribeiro, Maria ;

Akerley, Wallace ;

Kelly, Karen ;

Limentani, Steven A. ;

Crawford, Jeffrey ;

Reimers, Hans-Joachim ;

Axelrod, Rita ;

Kashala, Oscar ;

Sheng, Shihong ;

Schiller, Joan H. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (31) :5025-5033

[23] WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT [J].

FOLKMAN, J .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01) :4-6

[24] Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer [J].

Fukuoka, M ;

Yano, S ;

Giaccone, G ;

Tamura, T ;

Nakagawa, K ;

Douillard, JY ;

Nishiwaki, Y ;

Vansteenkiste, J ;

Kudoh, S ;

Rischin, D ;

Eek, R ;

Horai, T ;

Noda, K ;

Takata, I ;

Smit, E ;

Averbuch, S ;

Macleod, A ;

Feyereislova, A ;

Dong, RP ;

Baselga, J .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2237-2246

[25] Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: A north central cancer treatment group study [J].

Galanis, E ;

Buckner, JC ;

Maurer, MJ ;

Kreisberg, JL ;

Ballman, K ;

Boni, J ;

Peralba, JM ;

Jenkins, RB ;

Dakhil, SR ;

Morton, RF ;

Jaeckle, KA ;

Scheithauer, BW ;

Dancey, J ;

Hidalgo, M ;

Walsh, DJ .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (23) :5294-5304

[26]

Gatzemeier U, 2004, J CLIN ONCOL, V22, p619S

[27] Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer [J].

Gatzemeier, U ;

Groth, G ;

Butts, C ;

Van Zandwijk, N ;

Shepherd, F ;

Ardizzoni, A ;

Barton, C ;

Ghahramani, P ;

Hirsh, V .

ANNALS OF ONCOLOGY, 2004, 15 (01) :19-27

[28] Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase III trial-INTACT1 [J].

Giaccone, G ;

Herbst, RS ;

Manegold, C ;

Scagliotti, G ;

Rosell, R ;

Miller, V ;

Natale, RB ;

Schiller, JH ;

von Pawel, J ;

Pluzanska, A ;

Gatzemeier, M ;

Grous, J ;

Ochs, JS ;

Averbuch, SD ;

Wolf, MK ;

Rennie, P ;

Fandi, A ;

Johnson, DH .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :777-784

[29] An NCICCTG phase I/pharmacokinetic study of the matrix metalloproteinase and angiogenesis inhibitor BAY 12-9566 in combination with 5-fluorouracil/leucovorin [J].

Goel, R ;

Chouinard, E ;

Stewart, DJ ;

Huan, S ;

Hirte, H ;

Stafford, S ;

Waterfield, B ;

Roach, J ;

Lathia, C ;

Agarwal, V ;

Humphrey, R ;

Walsh, W ;

Matthews, S ;

Seymour, L .

INVESTIGATIONAL NEW DRUGS, 2005, 23 (01) :63-71

[30] Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent [J].

Gouyer, V ;

Conti, M ;

Devos, P ;

Zerimech, F ;

Copin, MC ;

Créme, E ;

Wurtz, A ;

Porte, H ;

Huet, G .

CANCER, 2005, 103 (08) :1676-1684

← 1 2 3 4 5 6 7 8 9 10 →